Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by standudu
Group name EquipeCTCS
Item Type Journal Article
Title Serum glial fibrillary acidic protein is a predictor of brain metastases in patients with metastatic breast cancer
Creator Darlix et al.
Author Amélie Darlix
Author Christophe Hirtz
Author Caroline Mollevi
Author Nelly Ginestet
Author Laurent Tiers
Author William Jacot
Author Sylvain Lehmann
Abstract In patients with metastatic breast cancer (MBC), brain metastases (BM) are associated with high morbidity and mortality. However, there is no validated serum biomarker that accurately predicts BM occurrence in these patients, and the role of serum biomarkers for prognosis remains unclear. Here, we evaluated the association of neurofilament light chain (NfL), ubiquitin C-terminal hydrolase L1 (UCHL1), glial fibrillary acidic protein (GFAP) and tau serum levels with BM presence and prognosis in patients with MBC. In serum samples from patients with MBC with (n = 100) and without BM (n = 47), we measured the biomarker serum levels using single molecule array (Simoa) technology (Neurology-4-Plex assay). To evaluate their accuracy to identify patients with BM, we determined the receiver operating characteristic curve and the area under the curve (AUC) for each biomarker and calculated their sensitivity and specificity. The median serum levels of NfL, UCHL1, tau and GFAP were significantly higher in patients with BM. The AUC for GFAP (0.82, 95% confidence interval [CI] 0.75-0.88) was significantly higher than those of the other biomarkers considered independently. Using the medians as cutoff values, elevated serum levels of NfL, UCHL1, tau and GFAP were associated with BM in univariate analysis, but only high GFAP levels in multivariate analysis (odd ratio 23.4, 95% CI 6.8-80.5, P
Publication International Journal of Cancer
Volume 149
Issue 8
Pages 1605-1618
Date 2021-10-15
Journal Abbr Int J Cancer
Language eng
DOI 10.1002/ijc.33724
ISSN 1097-0215
Library Catalog PubMed
Extra PMID: 34196964
Tags Adult, Biomarkers, Tumor, Brain Neoplasms, breast cancer, Breast Neoplasms, clinic, Combined Modality Therapy, Female, Follow-Up Studies, Glial Fibrillary Acidic Protein, glial fibrillary astrocytic protein, Humans, marque, Middle Aged, neurofilament light chain, original, Prognosis, Retrospective Studies, ROC Curve, Survival Rate, UCHL1 protein
Date Added 2022/07/29 - 15:47:54
Date Modified 2023/11/14 - 14:57:42
Notes and Attachments PubMed entry (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés